Mercalot Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q4 2025.
-
Location
-
Valencia, Spain
-
Fiscal year end
-
30 June
-
Latest financial report
-
22 Jan 2026
Latest SEC snapshot (2026-01-22) highlights Return On Equity 178.8%, Return On Assets -90.5%, and Operating Margin -281.4%.
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
28.1/100
Weak
Confidence medium
Return On Equity
179%
Metric score 100.0/100
Return On Assets
-91%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0.2x
- Debt to Equity
- -3.56x
Strengths
Return On Equity
Watchpoints
Return On Assets, Operating Margin, and Current Ratio
Financial Health
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
0.2x
|
+17%
|
Q4 2025
|
Q2 2026
|
x
|
|
Debt-to-equity
|
-3.56x
|
|
Q4 2025
|
Q2 2026
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Revenues
|
$16,960
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
NetIncomeLoss YoY
|
-117%
|
|
Q4 2025
|
Q2 2026
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
5,735,200
|
+42%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Shares, Outstanding
|
5,735,200
|
+42%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Value, Issued
|
$574
|
+42%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
5,735,200
|
+79%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
5,735,200
|
+79%
|
Q4 2025
|
Q2 2026
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
General and Administrative Expense
|
$55,285
|
+220%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Operating Income (Loss)
|
$47,733
|
-117%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Income Tax Expense (Benefit)
|
$0
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Earnings Per Share, Basic
|
0
|
|
Q4 2025
|
Q2 2026
|
USD/shares
|
|
Earnings Per Share, Diluted
|
0
|
|
Q4 2025
|
Q2 2026
|
USD/shares
|
|
Cash and Cash Equivalents, at Carrying Value
|
$19,046
|
+70%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Assets, Current
|
$19,046
|
+70%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Intangible Assets, Net (Excluding Goodwill)
|
$32,888
|
-22%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Assets
|
$51,934
|
-2.9%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Accounts Payable, Current
|
$20,000
|
|
Q4 2025
|
Q2 2026
|
USD
|
|
Liabilities, Current
|
$94,022
|
+45%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Liabilities
|
$94,022
|
+45%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$69,740
|
-217%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$42,088
|
-272%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Liabilities and Equity
|
$51,934
|
-2.9%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Common Stock, Shares Authorized
|
75,000,000
|
0%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Shares, Issued
|
5,735,200
|
+42%
|
Q4 2025
|
Q2 2026
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0.0001
|
0%
|
Q4 2025
|
Q2 2026
|
USD/shares
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$19,046
|
+70%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Deferred Tax Assets, Valuation Allowance
|
$6,603
|
+43%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Deferred Tax Assets, Operating Loss Carryforwards
|
$6,603
|
+43%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Additional Paid in Capital
|
$27,078
|
+163%
|
Q4 2025
|
Q2 2026
|
USD
|
|
Deferred Tax Assets, Net of Valuation Allowance
|
$0
|
|
Q4 2025
|
Q2 2026
|
USD
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Explore related SEC datasets